PBE : Invesco Dynamic Biotechnology & Genome ETF

PBE is a Sector Equity Market Healthcare with MODERATE fees.

PBE

Invesco Dynamic Biotechnology & Genome ETF

FI Score

51 /100

Diversification Rating

10 /10

Expense Ratio Rating

7 /10

Expense Rating

4 /10

Market Score

3 /10

Category Score

0 /10

Market Size

3 /10

51% FI Score
  • pbe
  • ETF
  • Sector Equity
  • Healthcare

Invesco Dynamic Biotechnology & Genome ETF

Expenses: 0.57% (Better than 1% of similar funds)

This is an OK choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Largest Holdings

Amount Holding
6.39% Catalent, Inc
5.92% Bio-Techne Corporation
5.85% Neurocrine Biosciences, Inc
5.61% Alexion Pharmaceuticals, Inc
5.56% Vertex Pharmaceuticals Incorporated
4.87% Amgen Inc
4.62% Gilead Sciences, Inc
4.27% Biogen Inc
3.58% Repligen Corporation
3.55% Emergent BioSolutions Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo